Your session is about to expire
← Back to Search
Web-based family health history tool for Breast Cancer (Progeny Trial)
N/A
Waitlist Available
Led By Melissa Frey, MD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Female > 18 years of age. Scheduled for new patient visit with one of the gynecologic oncologists at Weill Cornell Medicine (Melissa Frey MD, Kevin Holcomb MD, Evelyn Cantillo MD, Eloise Chapman MD).
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up anytime between 18 - 24 months
Awards & highlights
Progeny Trial Summary
This trial is testing a web-based tool to help collect family health histories in order to better assess a patient's risk of genetic disease.
Eligible Conditions
- Gynecologic Cancers
- Breast Cancer
- BRCA1
- BRCA2 Mutation
Progeny Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowProgeny Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ anytime between 18 - 24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~anytime between 18 - 24 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Proportion of subjects with high quality family health history (FHH)
Progeny Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: OfficeExperimental Treatment1 Intervention
Patient presents to new Gynecologic Oncology appointment, subject is given access to a desk top computer in office and instructed to complete web-based family health history tool. Physician reviews results of patients web-based family health history tool.Subject and physician complete assessment survey at the completion of clinic visit. Subject's medical record reviewed 6 months following study enrollment to determine subject's diagnosis, whether or not subject underwent genetic counseling and/or genetic testing and review genetic testing results.
Group II: HomeExperimental Treatment1 Intervention
Patient is emailed a link containing web-based family health history tool prior to presenting for new Gynecologic Oncology appointment. Physician reviews results of patients web-based family health history tool. Subject and physician complete assessment survey at the completion of clinic visit. Subject's medical record reviewed 6 months following study enrollment to determine subject's diagnosis, whether or not subject underwent genetic counseling and/or genetic testing and review genetic testing results.
Group III: Standard of CareActive Control1 Intervention
Patient presents to new Gynecologic Oncology appointment, family health history is collected by the physician during the clinic visit. Both the subject and physician complete assessment survey at the completion of clinic visit. Subject's medical record reviewed 6 months following study enrollment to determine subject's diagnosis, whether or not subject underwent genetic counseling and/or genetic testing and review genetic testing results.
Find a Location
Who is running the clinical trial?
Weill Medical College of Cornell UniversityLead Sponsor
1,054 Previous Clinical Trials
1,316,395 Total Patients Enrolled
29 Trials studying Breast Cancer
26,966 Patients Enrolled for Breast Cancer
Melissa Frey, MDPrincipal InvestigatorWeill Medical College of Cornell University
1 Previous Clinical Trials
660 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is geriatric participation being considered in this clinical trial?
"This clinical trial is recruiting those over 18 and under 100 years of age."
Answered by AI
Are any individuals currently being enrolled for this research?
"According to clinicaltrials.gov, the trial posted on September 9th 2019 is no longer recruiting participants; however, there are 1,474 other trials actively enrolling patients at this time."
Answered by AI
To whom is this research opportunity available?
"Eligibility criteria for this trial necessitate that potential participants have breast cancer and are between 18 to 100 years old. In total, 250 people need to be recruited."
Answered by AI
Share this study with friends
Copy Link
Messenger